Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Monogenic diabetes caused by inactivating mutation(s) in the PDX1 gene, encoding pancreas/duodenum homeobox protein 1. Homozygous PDX1 mutations result in permanent neonatal diabetes.
Features include: Maturity-onset diabetes of the young and Type II diabetes mellitus.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Hormones | 2 | Maturity-onset diabetes of the young, Type II diabetes mellitus |
Age of onset: adulthood.
PDX1 function has not been fully characterized.
Maturity-onset diabetes of the young type 4 is associated with mutations in the PDX1 gene on chromosome 13.
Genetic testing for PDX1 is available. Testing is considered confirmatory for diagnosis.
1 clinical trial registered. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
15 publications have been identified in PubMed for maturity-onset diabetes of the young type 4. Research spans Case Report / Case Series (27%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (27%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 4 | 27% |
Data assembled from 6 of 12 sources · Last updated Sep 21, 2026, 12:31 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Laboratory research |
4 |
27% |
Disease patterns and progression | 4 | 27% |
Research summaries | 3 | 20% |
Sharp LN (2026). [PMID: 41175096](https://pubmed.ncbi.nlm.nih.gov/41175096/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Tasoudis P (2026). [PMID: 41816471](https://pubmed.ncbi.nlm.nih.gov/41816471/). *J Thorac Dis*. [Epidemiology / Natural History]
Yoshiji S (2026). [PMID: 40853921](https://pubmed.ncbi.nlm.nih.gov/40853921/). *J Clin Endocrinol Metab*. [Epidemiology / Natural History]
Ahmed EM (2026). [PMID: 41898807](https://pubmed.ncbi.nlm.nih.gov/41898807/). *Genes (Basel)*. [Basic Science / Preclinical]
Laver TW (2026). [PMID: 41772234](https://pubmed.ncbi.nlm.nih.gov/41772234/). *Diabetologia*. [Review / Meta-Analysis]
Harten A (2025). [PMID: 41199860](https://pubmed.ncbi.nlm.nih.gov/41199860/). *Front Endocrinol (Lausanne)*. [Basic Science / Preclinical]
Sanri A (2025). [PMID: 41367630](https://pubmed.ncbi.nlm.nih.gov/41367630/). *Pediatr Diabetes*. [Case Report / Case Series]
Sriram A (2025). [PMID: 40779032](https://pubmed.ncbi.nlm.nih.gov/40779032/). *Diabetes*. [Basic Science / Preclinical]
Müssig K (2025). [PMID: 39379059](https://pubmed.ncbi.nlm.nih.gov/39379059/). *Exp Clin Endocrinol Diabetes*. [Review / Meta-Analysis]
Werner C (2025). [PMID: 39342034](https://pubmed.ncbi.nlm.nih.gov/39342034/). *Inn Med (Heidelb)*. [Case Report / Case Series]